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Accepted 21 September 2013In this report, we describe two adult brothers affected by moderate
non-speciﬁc intellectual disability (ID). They showed minor facial
anomalies, not clearly ascribable to any speciﬁc syndromic patterns,
microcephaly, brachydactyly and broad toes. Both brothers presented
seizures. Karyotype, subtelomeric and FMR1 analysis were normal in
both cases.
We performed array-CGH analysis that revealed no copy-number
variations potentially associated with ID. Subsequent exome sequence
analysis allowed the identiﬁcation of the ATRX c.109CNT (p.R37X)
mutation in both the affected brothers. Sanger sequencing conﬁrmed
the presence of the mutation in the brothers and showed that the
mother is a healthy carrier.
Mutations in the ATRX gene cause the X-linked alpha thalassemia/
mental retardation (ATR-X) syndrome (MIM#301040), a severe clinical
condition usually associated with profound ID, facial dysmorphism and
alpha thalassemia. However, the syndrome is clinically heterogeneous
and some mutations, including the c.109CNT, are associated with a
broad phenotypic spectrum, with patients displaying a less severe
phenotype with only mild-moderate ID. In the case presented here,Keywords:
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molecular diagnosis of ATR-X syndrome, which otherwise would have
been difﬁcult to consider due to the mild non-speciﬁc phenotype and
the absence of a family history with typical severe cases.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.1. Introduction
Intellectual disability (ID) affects approximately 1–3% of the general population and is diagnosed upon the
concomitant occurrence of three fundamental criteria: an intelligence quotient (IQ) below 70, signiﬁcant
limitations in two or more adaptive skill areas, and the presence of the condition from childhood (before the
age of 18 years).
Causes of ID can be either genetic, including chromosomal and single gene disorders, or non-genetic, such
as problems during pregnancy, at birth and after birth, as well as poverty and cultural deprivation (Ropers,
2010). Although such environmental inﬂuences can cause ID, gene mutation and structural rearrangements
of the genome are now considered to be the most important factors in this disorder (Firth and Carter, 2010).
Genetic ID can be subdivided into syndromic forms, which are characterized by ID accompanied by either
malformations, or dysmorphic features, or neurological abnormalities, and non-syndromic forms, which are
characterized by ID without any additional features. A great effort has been made over recent years to
improve knowledge on the genetic basis of ID, which has lead to the identiﬁcation of several genes implicated
in both syndromic and non-syndromic forms, the majority of them mapped to the X chromosome (Ropers,
2010). Despite these recent advances, the etiology of ∼60% of cases of ID is still unknown. The application of
exome sequencing promises to rapidly reduce the number of such unexplained cases, allowing the
identiﬁcation of disease causing variants in both known and yet unknown ID genes (Topper et al., 2011).
We report here on two adult brothers affected by moderate ID and dysmorphic peculiar minor facial
anomalies which did not ﬁt a speciﬁc syndromic pattern. We exploited the whole-exome sequencing
strategy in order to identify the causative genetic defect and found the c.109CNT (p.R37X) mutation in the
X-linked alpha thalassemia/mental retardation (ATR-X) syndrome (MIM #301040) causing gene, ATRX.
This ATRX mutation is often linked to a mild and non-speciﬁc phenotype. Our study provides evidence of
the usefulness of the exome sequencing technique for the achievement of a rapid and certain molecular
diagnosis of idiopathic ID cases.
2. Clinical report
2.1. Patient 1 (III-6, Fig. 1b)
Patient III-6 was evaluated at the age of 38 years. He is amale, second born of healthy non-consanguineous
Caucasian parents, aged 23 and 25 years at time of conception. First born (III-5) is a healthy male. Third born
will be described later as Patient III-7. The family history was otherwise unremarkable and negative for ID or
birth defects. Aﬁrst grade cousin (from the father's side) died at eightmonths of life, as reported, formeningitis
secondary to otitis (Fig. 1a).
The child was spontaneously delivered at term after an uneventful pregnancy. His birth weight was
3200 g (10th centile). Other neonatal auxological parameters are unknown. Growth parameters were
reported to be at the lower limits of the normal range until the eighth month of life and then they were
regular, while gross motor, cognitive and social milestones were retarded: he walked without support and
took his ﬁrst steps at two years of age and he spoke his ﬁrst words at the age of three years. At eight months
he developed a tonic–clonic seizure in hyperpyrexia. At 2 years, he developed myoclonic absences that
were controlled by anticonvulsants. At that time, EEG detected bilaterally widespread cortico-subcortical
abnormalities. Cranial Magnetic Resonance Imaging (MRI), performed at 38 years, showed microcrania with
a more evident reduction of frontal lobes and moderate cerebellar atrophy, more marked against the worm
with extension of sub-arachnoid space in the posterior fossa.
On our evaluation, at the age of 38 years, his auxological parameters were: weight 79 kg (90–97th
centile); height 174 cm (25–50th centile); and OFC 56 cm (50–75th centile). He had a long face with a
small forehead, bushy eyebrows, prominent nasal root and tip, thickened helix, arched palate and broad
Fig. 1. Family tree (a) and facial features of the two affected brothers (b, c). (a) A ﬁrst grade cousin (from the father's side) died at eight months of life, as reported, for meningitis secondary to otitis;
(b) patient III-6, aged 38 years, exhibiting minor dysmorphic features, including long face with small forehead, bushy eyebrows, prominent nasal root and tip, thickened helix, arched palate, and
broad lips; (c) patient III-7, aged 36 years, shows mild microcephaly, a long face with a small forehead, prominent nasal bridge and tip, thickened helix, arched palate, and short neck.
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105S. Moncini et al. / Meta Gene 1 (2013) 102–108lips (Fig. 1b). In addition, he had brachydactyly of fourth and ﬁfth ﬁngers, stubby ﬁrst toes, proximal
attachment of fourth and ﬁfth toes, and valgus knee. Ophthalmologic examination, as well as cardiac and
renal ultrasounds was normal. Aminoacidemia/uria was normal. Neuropsychological evaluation by WAIS-R
showed moderate ID with VIQ 53, PIQ 57 and FSIQ 50.
2.2. Patient 2 (III-7, Fig. 1c)
Patient III-7 is case III-6's brother. The child was spontaneously delivered at term after an uneventful
pregnancy. His birth weight was 3000 g (10th centile). Other neonatal auxological parameters are unknown.
Growth parameters were reported to be at the lower limits of the normal range until the eighthmonth of life
and then theywere regular,while grossmotor, cognitive and socialmilestoneswere retarded: he tookhisﬁrst
steps at the age of two years, he walked without support and spoke his ﬁrst words at three years of age. At
eight months he developed a tonic–clonic seizure in hyperpyrexia. At 2 years, he developed myoclonic
absences that were controlled by anticonvulsants. At the age of ten years, a neuropsychological evaluation
showed a moderate intellectual disability. At 26 years he developed behavioral problems controlled
by antipsychotic drugs. Cranial Magnetic Resonance Imaging (MRI), performed at 36 years, showed a
microcrania and microcephaly with more evident reduction of frontal lobes.
At time of our evaluation his auxological parameters were: weight 79 kg (90–97th centile); height
175 cm (50th centile); and CC: 53 cm (3rd centile). He had mild microcephaly, a long face with a small
forehead, bushy eyebrows, prominent nasal bridge and tip, thickened helix, arched palate, short neck
(Fig. 1c), brachydactyly, broad and stubby ﬁrst toes with proximal attachment, and mild valgus knee.
Neuropsychological evaluation by WAIS-R showed moderate ID with VIQ 55, PIQ 54 and FSIQ 49.
3. Materials and methods
Informed consent was obtained from the parents for the molecular analysis and for the reproduction of
photographs.
GenomicDNAwas isolated fromperipheral blood samples using theQIAampDNAbloodmini kit (Qiagen).
Array-based Comparative Genome Hybridization (a-CGH) was performed on the Agilent oligo-a-CGH 244K,
which includes 236,000 60 nmer long oligonucleotide probes (both coding and non-coding sequences), with
an average spatial resolution of ~30 kb.
Exome sequence analysis was carried out on an Illumina HiSeq platform after exome capture
using the Agilent SureSelect Human All Exon 50 M kit (BGI Hong Kong Co.). For Sanger sequencing
detection of the c.109CNT ATRX mutation, blood derived DNA was PCR ampliﬁed using ATRX-Fw:
5′-GCCTCCTGAGTAGCTGAGAC-3′ and ATRX-Rev: 5′-GCTTGCTAATCTGTCATTTTCCA-3′ primers, sequenced
using the BigDye Terminator Cycle Sequencing Ready Kit (Life Technologies Corporation), and run on an
automated ABI-3130xl DNA genetic analyzer (Applied Biosystems).
4. Molecular results
Routine chromosome analysis and FISH (ﬂuorescent in situ hybridization) analysis with subtelomeric
speciﬁc clones as well as molecular testing of FMR1 were normal in both patients. In order to rule out subtle
genomic rearrangements as the possible cause of ID, an array-based Comparative Genomic Hybridization
analysis was carried out, which however revealed no copy-number variations (CNVs) potentially associated
with ID.
The subsequent exome sequence analysis showed the presence of the c.109CNT (p.R37X) nonsense
mutation in exon 2 of the ATRX gene (chr. Xq13) in both patients but not in their healthy brother.
Traditional Sanger sequencing conﬁrmed the presence of the mutation in the affected brothers and
showed that the mother is a healthy carrier (Fig. 2).
5. Discussion
Mutations in the ATRX gene, mapped to Xq13, cause the X-linked alpha thalassemia mental retardation
(ATR-X) syndrome (MIM #301040), a rare disease with an estimated prevalence of b1–9/100,000 live
Fig. 2. Detection of the c.109CNT (p.R37X) mutation in the two affected brothers (III-6 and III-7) by sequence analysis of ATRX exon 2. The mutation was also detected in the heterozygous state in
their mother.
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107S. Moncini et al. / Meta Gene 1 (2013) 102–108born males (Gibbons, 2006) and only about 170 cases reported worldwide (Jezela-Stanek et al., 2009). In
addition, other phenotypically overlapping conditions, such as Carpenter–Waziri syndrome or Juberg–
Marsidi syndrome (Villard et al., 1996; Abidi et al., 1999), are caused by mutations in the ATRX gene. ATRX
spans about 300 kb of genomic DNA, contains 36 exons and encodes a member of the SNF2 family of
adenosine triphosphatase/helicases, with a role in chromatin remodeling and gene expression (Tang et al.,
2004; Gibbons et al., 2008). The individuals affected by ATR-X syndrome are almost exclusively male and
the usual ﬁndings are profound developmental delay and ID (present in N95% of cases), genital
abnormalities (85%), alpha thalassemia (80%) and a typical facial appearance (Gibbons, 2006). However,
the syndrome is clinically heterogeneous and a fewmutations, including the c.109CNT variant identiﬁed in
our cases, are associated with a broad phenotypic spectrum, with patients displaying a less severe
phenotype with the absence of typical features of the syndrome and only mild-moderate ID (Gibbons et
al., 2008; Yntema et al., 2002). The c.109CNT mutation was ﬁrst discovered by Guerrini et al. (2000) in a
family with two individuals with mild ID and absence of typical features, in whom the ATR-X syndrome
was only suspected after it had been clinically diagnosed in two other family members who presented
severe ID and the characteristic features of the syndrome. The phenotypic variability linked to this
nonsense mutation in ATRX exon 2, as well as to other nonsense mutations identiﬁed in the ATRX gene, can
be ascribed to the presence of a residual amount of wild-type protein, maybe by initiation of translation at
a downstream methionine or alternative splicing (Howard et al., 2004; Abidi et al., 2005).
In our cases, ﬁrst evaluated in adulthood, the clinical features overlapped with the phenotypic
spectrum of the syndrome solely in the presence of skeletal abnormalities, seizures and, only as far as
patient III-7 is concerned, microcephaly. Instead, they lacked the other speciﬁc signs of the syndrome, such
as speciﬁc minor facial anomalies, genital abnormalities and, most importantly, profound ID (Table 1).
Moreover, the characteristic facial features of ATR-X syndrome, consisting of upswept frontal hair line,
hypertelorism, epicanthic folds, ﬂat nasal bridge, small triangular upturned nose, retracted columella,
tented upper lip, everted lower lip and hypotonic facies were mainly absent. In addition to this, since
neither patient had symptoms of anemia, the presence of HbH inclusions was not evaluated.
The exome sequencing technique represented here an effective tool for arriving at the molecular
diagnosis of ATR-X syndrome, which otherwise would have been difﬁcult to consider due to the relatively
mild and non-speciﬁc phenotype of the two affected brothers and the lack of a family history with typical
severe cases (Guerrini et al., 2000), also avoiding time-consuming screening of candidate genes. SeveralTable 1
Comparison of clinical features between previous ATR-X cases and the patients reported here.
Modiﬁed from Guerrini et al., Ann Neurol 2000; 47:117–121.
Clinical features ATR-X syndrome (%) Patients
III-6 III-7
Age 38 years 36 years
Severe/profound ID 95 − −
Weschler IQ scores
FSIQ 50 49
Verbal score 53 55
Performance score 57 54
Skeletal abnormalities 90 + +
Characteristic face N90 − −
Hemoglobin H inclusions 85 ne ne
Neonatal hypotonia 93 − −
Genital abnormalities 80 − −
Gut dysmotility 95 ne ne
Microcephaly 75 − +
Short stature 65 − −
Seizures 30 + +
Cardiac defects 20 − −
Renal/urinary abnormalities 15 − −
Legend:
FSIQ: full scale intelligence quotient.
ne: not evaluated.
108 S. Moncini et al. / Meta Gene 1 (2013) 102–108genes have been identiﬁed so far, and many others are likely to be discovered in the near future, which can
give rise to both syndromic and non-syndromic forms of ID (Ropers, 2010). The application of exome
sequencing to the diagnosis of ID, besides increasing the speed at which unknown ID genes are revealed,
will also help to uncover further sporadic or familial cases with mutations in already known causative
genes but with non-speciﬁc phenotype, thereby improving genetic counseling to the affected families.
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